sur Entero Therapeutics (NASDAQ:ENTO)
GridAI Technologies Corp Names Marshall Chapin as CEO of Subsidiary
GridAI Technologies Corp (NASDAQ: GRDX) has appointed Marshall Chapin as CEO of its subsidiary focusing on next-gen grid and power management software for AI data-center campuses. Chapin, with over 30 years of leadership in energy-transition and grid-optimization, was previously Chief Commercial Officer and Interim CEO at Amp X, another GridAI subsidiary.
His appointment highlights GridAI's dedication to developing an orchestration engine for AI data-center power demands. Chapin's past roles include Chief Revenue Officer at SYSO Technologies and Chief Customer Officer at Eos Energy Enterprises.
This change comes as AI infrastructure investments rise globally, with AI-data-center market predicted to exceed $1 trillion by 2030. GridAI’s platform offers AI-driven solutions for emerging hyperscale campuses.
R. E.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Entero Therapeutics